General MedicationsORALGeneric
LORAZEPAM
LORAZEPAM
Standard Dose
2MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview LORAZEPAM is listed in Drugs@FDA under application 200169 (ANDA).
Marketing status: Discontinued Active ingredient LORAZEPAM Form and strength CONCENTRATE;ORAL - 2MG/ML Sponsor HIKMA Submission history Latest submission status date: 2012-01-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview LORAZEPAM is listed in Drugs@FDA under application 200169 (ANDA). Marketing status: Discontinued Active ingredient LORAZEPAM Form and strength CONCENTRATE;ORAL - 2MG/ML Sponsor HIKMA Submission history Latest submission status date: 2012-01-30 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.